Influence of CYP2C9 and VKORC1 on Warfarin Response during Initiation of Therapy

Por Limdi, NA, Wiener, H, Goldstein, JA, Acton, RT, Beasley, TM
Publicado em 2009

Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans

Por Limdi, NA, Goldstein, JA, Blaisdell, JA, Beasley, TM, Rivers, CA, Acton, RT
Publicado em 2007

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European American and African Americans

Por Limdi, NA, Arnett, DK, Goldstein, JA, Beasley, TM, McGwin, G, Adler, BK, Acton, RT
Publicado em 2008

Influence of CYP2C9 and VKORC1 1173C/T Genotype on the Risk of Hemorrhagic Complications in African-American and European-American Patients on Warfarin

Por Limdi, NA, McGwin, G, Goldstein, JA, Beasley, TM, Arnett, DK, Adler, BK, Baird, MF, Acton, RT
Publicado em 2007